Stocktoria
KALA BIO, Inc. KALA
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2017-07-20
KALA BIO, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | -2099.3% | -1158.8% | -1512.6% | -1452.5% | — | — | — |
| Net margin | — | — | — | -1151.6% | -1268.7% | -1639.8% | -1553.3% | — | — | — |
| FCF margin | — | — | — | — | — | — | -1548.5% | — | — | — |
| Return on assets | -284.3% | -69.4% | -75.4% | -51.6% | -102.3% | -47.1% | -61.1% | -30.2% | -36.2% | -71.6% |
| Return on equity | -385.6% | -312.3% | -562.4% | -236.2% | -848.6% | -104.3% | -317.8% | -63.6% | -47.1% | 37.8% |
| Debt / equity | — | 2.37× | 4.56× | 2.28× | 4.76× | 0.75× | 2.53× | 0.71× | 0.21× | -0.10× |
| Current ratio | 3.81 | 3.11 | 6.33 | 3.35 | 3.32 | 7.71 | 4.26 | 10.41 | 7.75 | 8.23 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.